Expression of N-cadherin in esophageal squamous cell carcinoma and silencing expression of N-cadherin using RNA interference on invasiveness of EC9706 cells.
OBJECTIVE
E- and N-cadherin are calcium-dependent cell adhesion molecules that mediate cell-cell adhesion and also modulate cell migration and tumor invasion. It has been suggested that, unlike E-cadherin, N-cadherin may promote invasion and metastasis of carcinoma. This study was to explore the correlation of E-cadherin and N-cadherin expression to clinicopathologic features of esophageal squamous cell carcinoma (ESCC), and to investigate the effect of silencing N-cadherin expression by RNA interference (RNAi) on the invasiveness of EC9706 cells.


METHODS
PV immunohistochemistry was used to detect the expression of E-cadherin and N-cadherin in 62 specimens of normal esophageal epithelium, 31 specimens of adjacent atypical hyperplasia epithelium and 62 specimens of ESCC. N-cadherin siRNA was transfected into EC9706 cells, and the effect of RNAi was assessed by RT-PCR and Western blot. The invasiveness of EC9706 cells was determined by Transwell chamber assay.


RESULTS
The positive rates of E-cadherin and N-cadherin were 95.2% and 29.0% in normal esophageal epithelium, 71.0% and 61.3% in adjacent atypical hyperplasia epithelium, 40.3% and 75.8% in ESCC. The negativity of E-cadherin and positivity of N-cadherin were correlated to invasion, differentiation, and lymph node metastasis of ESCC (p < 0.05). E-cadherin expression was negatively correlated to N-cadherin expression in ESCC (gamma = -0. 534, p < 0.05). N-cadherin RNAi significantly inhibited N-cadherin expression in EC9706 cells, and decreased the number of EC9706 cells that invaded through the basement membrane from (123.40 +/- 8.23) to (49.60 +/- 6.80) (p < 0.05).


CONCLUSIONS
Down-regulation of E-cadherin and up-regulation of N-cadherin may be involved in the genesis of ESCC. Silencing N-cadherin using RNA interference could inhibit the invasiveness of EC9706 cells in vitro.
Li
Ke
K
Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, PR China.
Wang
Xin
X
He
Wei
W
Lin
Na
N
Fan
Qing-Xia
QX
D000328:Adult; D000368:Aged; D015820:Cadherins / Q000032:analysis / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D004938:Esophageal Neoplasms / Q000473:pathology*; D005260:Female; D020868:Gene Silencing; D006801:Humans; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000032:analysis / Q000235:genetics; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D034622:RNA Interference; D012190:Retroviridae / Q000235:genetics; D014162:Transfection
D015820:Cadherins; D020780:Matrix Metalloproteinase 9